Oxford Biomedica (OXB)

Sector:

Pharma and Biotech

Index:

FTSE 250

629.00p
   
  • Change Today:
      1.00p
  • 52 Week High: 913.00
  • 52 Week Low: 307.00
  • Currency: UK Pounds
  • Shares Issued: 121.01m
  • Volume: 58,113
  • Market Cap: £761.16m
  • RiskGrade: 125
  • Beta: 0.03

Latest ShareCast News

Oxford Biomedica reiterates full-year guidance, flags first-half loss

By Abigail Townsend

Date: Thursday 26 Mar 2026

(Sharecast News) - Oxford Biomedica posted a surge in annual revenues on Thursday, but warned it was on track to swing to an interim loss this year before returning to growth in the second half.

EQT not planning to bid for Oxford Biomedica

By Michele Maatouk

Date: Wednesday 25 Feb 2026

(Sharecast News) - Oxford Biomedica shares slumped on Wednesday after Swedish private equity firm EQT said it was not planning to make an offer for the gene and cell therapy company.

Oxford Biomedica FY revenues grow, one‑off gain props up earnings

By Iain Gilbert

Date: Tuesday 24 Feb 2026

(Sharecast News) - Contract development and manufacturing firm Oxford Biomedica said on Tuesday that it expects to report a strong rise in full year revenues, but signalled that underlying profitability would only be modest despite a one‑off boost from its US acquisition.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

OXB Market Data

Currency UK Pounds
Share Price 629.00p
Change Today 1.00p
% Change 0.16 %
52 Week High 913.00
52 Week Low 307.00
Volume 58,113
Shares Issued 121.01m
Market Cap £761.16m
Beta 0.03
RiskGrade 125

OXB Star Ratings

Compare performance with the sector and the market.
more star ratings
Key: vs Market vs Sector
Value
35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average35.16% below the market average
17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average17.07% above the sector average
Price Trend
84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average84.11% above the market average
86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average86.36% above the sector average
Income Not Available
Growth
5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average5.07% above the market average
24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average24.14% below the sector average

What The Brokers Say

Strong Buy 5
Buy 2
Neutral 3
Sell 0
Strong Sell 0
Total 10
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

OXB Dividends

No dividends found

Trades for 01-Jun-2026

Time Volume / Share Price
13:42 0 @ 629.00p
13:42 3 @ 629.00p
13:40 0 @ 629.00p
13:40 1 @ 629.00p
13:37 4 @ 626.51p

OXB Key Personnel

Chair Roch Doliveux
CEO Frank Mathias
CFO Lucinda (Lucy) Crabtree

Top of Page